ARCHIVES

ImClone Offered C225 Deal To Seven Firms Prior To BMS

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

Community Centers Group Lines Up A Speaker

January 10, 1975

Bayh To Receive ACCC Annual Award

February 8, 1980

FDA Subcommittee Leaning Toward Mouse-Dog Drug Testing New Preclinical Toxicity-Protocol

July 20, 1979

Bush Appoints Kripke To President’s Cancer Panel

March 21, 2003

DCE Board Demands Other Agencies Pay For NCI AIDS Support Contract, Okays Two RFA Concepts, One Program Announcement, Contract Recompetitions

May 24, 1985